Julie Hallet, Chair, Equity Diversity and Inclusion Group at IHPBA, shared a post by Giovanni Marchegiani, at

“1 of 3 PNETs potentially over-treated especially small PNETs in expert centre (higher elsewhere) Same OS over vs appropriate treatment 25% overtreated pts have unnecessary morbidity.

We can harm patients NET MCC over treatment One of my fave this year.“

Quoting Giovanni Marchegiani’s post:

“Surgery for non functioning pancreatic neuroendocrine tumors.

Are we harming our patients.

Almost 400 resected P-NET with path and FU analysis %

Inadequate treatment (34% potential overtreatment)

Size only reliable predictor.“

Critical appraisal of the adequacy of surgical indications for non-functioning pancreatic neuroendocrine tumours

Authors: Stefano Partelli, Anna Battistella, Valentina Andreasi, Francesca Muffatti, Domenico Tamburrino, Nicolò Pecorelli, Stefano Crippa, Gianpaolo Balzano, and Massimo Falconi.

Julie Hallet: 1 of 3 PNETs potentially over-treated especially small PNETs in expert centre

For more information.

Source: Julie Hallet/X and Giovanni Marchegiani/X

Julie Hallet: 1 of 3 PNETs potentially over-treated especially small PNETs in expert centre